← Back to Search

Other

Therapy for Cancer

N/A

Recruiting

Research Sponsored by British Columbia Cancer Agency

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Ability to give informed consent for the study procedures defined in this protocol

ECOG 0-2

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from date of initiation until the date of death from any cause, whichever came first, assessed up to 100 months

Awards & highlights

Study Summary

This trial is looking to see how well a new therapy works for cancer patients in real life. The researchers want to see if the therapy improves quality of life and helps patients live longer. They hope this

Who is the study for?

This trial is for cancer patients who are interested in participating in a study that evaluates their quality of life and survival with treatments that have shown some promise but need more data to confirm their effectiveness.Check my eligibility

What is being tested?

The trial is testing how certain cancer treatments affect the real world outcomes of patients. It involves regular check-ups using scans or lab tests, along with surveys about the patient's quality of life (QOL).See study design

What are the potential side effects?

Since specific interventions aren't listed, side effects will vary based on individual treatments received. Generally, they could include typical cancer treatment side effects like fatigue, nausea, pain, and potential impact on blood counts.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I understand and agree to the study's procedures.

Select...

I am able to care for myself and perform daily activities.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from date of initiation until the date of death from any cause, whichever came first, assessed up to 100 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from date of initiation until the date of death from any cause, whichever came first, assessed up to 100 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and from date of initiation until the date of death from any cause, whichever came first, assessed up to 100 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Overall survival

Secondary outcome measures

Physician assessed response rate

Progression/event free survival

Quality adjust survival

+2 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: TherapyExperimental Treatment2 Interventions

Regular disease assessment (eg radiographic imaging) and QOL questionnaires

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

QOL

2001

N/A

~30

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

British Columbia Cancer AgencyLead Sponsor

171 Previous Clinical Trials

90,411 Total Patients Enrolled

Cheryl Ho, MDStudy ChairBC Cancer

4 Previous Clinical Trials

1,571 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment for this study currently open?

"Per information from clinicaltrials.gov, this research is presently seeking suitable participants. The trial was first made available on January 22nd, 2024, and underwent its last revision on February 2nd of the same year."

Answered by AI

What is the current number of individuals participating in this research project?

"Yes, the details on clinicaltrials.gov show that this clinical study is actively enrolling volunteers. The trial was initially listed on January 22nd, 2024 and last updated on February 2nd, 2024. This research seeks to recruit a total of 100 participants from one location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Evidence Development in Cancer Treatment - Real World: PREDiCTrw

2024. "Evidence Development in Cancer Treatment - Real World: PREDiCTrw". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06242912.